Regulatory Support. If requested by CUMBERLAND, and at CUMBERLAND’S cost at reasonable fees to be agreed by the parties, FAULDING shall provide CUMBERLAND with reasonable assistance in relation to the Development of, and applications for regulatory approval for, pharmaceutical products other than the Drug Product which are identified by CUMBERLAND, including but not limited to the preparation of development reports, stability reports, manufacturing documentation and instructions for use necessary to support applications for regulatory approval.
Appears in 3 contracts
Sources: Strategic Alliance Agreement (Cumberland Pharmaceuticals Inc), Strategic Alliance Agreement (Cumberland Pharmaceuticals Inc), Strategic Alliance Agreement (Cumberland Pharmaceuticals Inc)